All sponsors

Hudson Biotech

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS8
PHASE 3 / 2-31
RECRUITING8
READOUTS ≤12 MONTHS8
Open Hudson Biotech on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
MTII-VIT
NCT07437560
P2RecruitingNonSegmental Vitiligo; Nonsegmental Vitiligo (Stable)602027-02-14
BPC-HAMSTR
NCT07437547
P2RecruitingHamstring Muscle Strain; Skeletal Muscle Injury1202027-02-14
CuHeal
NCT07437586
P2RecruitingAcute Standardized Cutaneous Wounds (Punch-biopsy Wounds)602027-02-14
MOTS-MET
NCT07505745
P2RecruitingPrediabetes; Insulin Resistance1202027-02-14
TBRIDGE-CV
NCT07487363
P1/2RecruitingAtherosclerotic Cardiovascular Diseases; Endothelial Dysfunction802027-02-14
TESA-LIVER
NCT07481734
P2RecruitingMetabolic Associated Steatotic Liver Disease; Nonalcoholic Steatohepatitis1202027-02-14
SURMOUNT-1
NCT07481747
P3RecruitingObesity; Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities25392027-02-14
GZBF
NCT07467447
P2RecruitingObesity3002027-03-14